These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29392142)

  • 21. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
    Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
    Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists.
    Janardana R; Haridas V; Priya V; Bhat V; Singh Y; Rao VK; Jois R; Srikantiah C; Pinto B; Shobha V
    Lupus; 2020 Oct; 29(11):1397-1403. PubMed ID: 32741300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data.
    Clowse MEB; Eudy AM; Balevic S; Sanders-Schmidler G; Kosinski A; Fischer-Betz R; Gladman DD; Molad Y; Nalli C; Mokbel A; Tincani A; Urowitz M; Bay C; van Noord M; Petri M
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35318256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
    Yang J; Yang X; Yang J; Li M
    J Rheumatol; 2018 Jun; 45(6):818-826. PubMed ID: 29545450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
    Miyagawa I; Nakano K; Nakayamada S; Iwata S; Hanami K; Fukuyo S; Kubo S; Kawabe A; Miyazaki Y; Inoue Y; Ueno M; Ohkubo N; Fujita Y; Tanaka Y
    Int J Rheum Dis; 2020 Apr; 23(4):549-558. PubMed ID: 32020727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine.
    Izmirly PM; Kim MY; Llanos C; Le PU; Guerra MM; Askanase AD; Salmon JE; Buyon JP
    Ann Rheum Dis; 2010 Oct; 69(10):1827-30. PubMed ID: 20447951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
    Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
    Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia.
    Al Arfaj AS; Khalil N
    Lupus; 2010 Dec; 19(14):1665-73. PubMed ID: 20947541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine in Lupus Pregnancy and Risk of Preeclampsia.
    Rector A; Marić I; Chaichian Y; Chakravarty E; Cantu M; Weisman MH; Shaw GM; Druzin ML; Simard JF
    Arthritis Rheumatol; 2024 Jun; 76(6):919-927. PubMed ID: 38272838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
    Garg S; Unnithan R; Hansen KE; Costedoat-Chalumeau N; Bartels CM
    Arthritis Care Res (Hoboken); 2021 May; 73(5):707-716. PubMed ID: 32004406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus.
    Schmajuk G; Yazdany J; Trupin L; Yelin E
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):386-92. PubMed ID: 20391485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus.
    Yoshida M; Minowa K; Amano H; Asai Y; Yamaji K; Tamura N
    Lupus; 2021 Aug; 30(9):1378-1384. PubMed ID: 33966540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
    Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
    Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.
    Buchanan NM; Toubi E; Khamashta MA; Lima F; Kerslake S; Hughes GR
    Ann Rheum Dis; 1996 Jul; 55(7):486-8. PubMed ID: 8774170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
    Zhang N; Zhang HX; Li YW; Li Y
    Drugs R D; 2023 Mar; 23(1):35-42. PubMed ID: 36449182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).
    Costedoat-Chalumeau N; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin du LT; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Tanguy ML; Hulot JS; Lechat P; Musset L; Amoura Z; Piette JC;
    Ann Rheum Dis; 2013 Nov; 72(11):1786-92. PubMed ID: 23144449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.
    Levy RA; Vilela VS; Cataldo MJ; Ramos RC; Duarte JL; Tura BR; Albuquerque EM; Jesús NR
    Lupus; 2001; 10(6):401-4. PubMed ID: 11434574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presumable effects of hydroxychloroquine and its metabolites in the treatment of systemic lupus erythematosus.
    Pan M; Jin R; Dai Y; Gao B; Liu Y; Peng X; Qiao J; Shuai Z
    Int Immunopharmacol; 2024 Jan; 126():111269. PubMed ID: 38006753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
    Fernandez-Ruiz R; Bornkamp N; Kim MY; Askanase A; Zezon A; Tseng CE; Belmont HM; Saxena A; Salmon JE; Lockshin M; Buyon JP; Izmirly PM
    Arthritis Res Ther; 2020 Aug; 22(1):191. PubMed ID: 32807233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.